Matt Simmes Succeeds Jeff Gendell as Chief Executive Officer of IES Holdings, Inc. GlobeNewswire July 01, 2025 HOUSTON, July 01, 2025 (GLOBE NEWSWIRE) — IES Holdings, Inc. (or “IES” or the “Company”) (NASDAQ: IESC) announced today that the Company completed its previously-announced executive succession plan, with Matt Simmes becoming the Company's President and Chief Executive […]
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of V.F. Corporation ("V.F. Corporation") (NYSE:VFC) concerning possible violations of federal securities laws. On May 21, 2025, VFC issued a press release announcing that the company’s fourth quarter fiscal 2025 results failed to
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Equinix, Inc. ("Equinix, Inc.") (NASDAQ:EQIX) concerning possible violations of federal securities laws. On June 25, 2025, during an Analyst Day event, Equinix shares plummeted as investors reacted to analyst and market sentiment
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=155061&wire=1&utm_campaign=26 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Fortrea Holdings Inc. (NASDAQ:FTRE) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/fortrea-holdings-inc-lawsuit-submission-form?prid=155060&wire=1&utm_campaign=31 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=155063&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your PepGen Inc. (NASDAQ:PEPG) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/pepgen-inc-lawsuit-submission-form?prid=155062&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Reckitt Benckiser Group plc (OTC PINK:RBGLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/reckitt-benckiser-group-plc-lawsuit-submission-form?prid=155051&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq. via email at
NEW YORK, NY / ACCESS Newswire / July 1, 2025 / If you suffered a loss on your Hims & Hers Health, Inc. (NYSE:HIMS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/hims-hers-health-inc-lawsuit-submission-form?prid=155049&wire=1&utm_campaign=15 or contact Joseph E. Levi, Esq. via email at